Welcome to LookChem.com Sign In|Join Free
  • or
5-(1-ethylpropyl)-1,3,4-thiadiazol-2-amine(SALTDATA: FREE) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

229003-14-9

Post Buying Request

229003-14-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

229003-14-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 229003-14-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,9,0,0 and 3 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 229003-14:
(8*2)+(7*2)+(6*9)+(5*0)+(4*0)+(3*3)+(2*1)+(1*4)=99
99 % 10 = 9
So 229003-14-9 is a valid CAS Registry Number.

229003-14-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-pentan-3-yl-1,3,4-thiadiazol-2-amine

1.2 Other means of identification

Product number -
Other names 5-(pentan-3-yl)-1,3,4-thiadiazol-2-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:229003-14-9 SDS

229003-14-9Relevant academic research and scientific papers

INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS

-

Page/Page column 15-16, (2012/03/10)

This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases, other than cancer and proteolytic enzyme mediated diseases, other than cancer, and pharmaceutical compositions for use in such therapy.

Discovery of novel aminothiadiazole amides as selective EP3 receptor antagonists

Hilfiker, Mark A.,Wang, Ning,Hou, Xiaoping,Du, Zhimin,Pullen, Mark A.,Nord, Melanie,Nagilla, Rakesh,Fries, Harvey E.,Wu, Charlene W.,Sulpizio, Anthony C.,Jaworski, Jon-Paul,Morrow, Dwight,Edwards, Richard M.,Jin, Jian

scheme or table, p. 4292 - 4295 (2010/05/18)

This Letter discloses a series of 2-aminothiadiazole amides as selective EP3 receptor antagonists. SAR optimization resulted in compounds with excellent functional activity in vitro. In addition, efforts to optimize DMPK properties in the rat are discussed. These efforts have resulted in the identification of potent, selective EP3 receptor antagonists with excellent DMPK properties suitable for in vivo studies.

INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS

-

Page/Page column 15, (2010/11/28)

Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 229003-14-9